Diagnosis of acute myocardial infarction (heart attack) Used especially when detected alongside ECG changes and clinical symptoms and was previously a primary diagnostic marker Assessment of the extent of myocardial damage Peak elevation generally correlates with the size of the affected area of the heart Detection of reinfarction In hospitalized patients with prior myocardial infarction where a new rise after normalization may indicate a new event Differentiation of cardiac versus non-cardiac chest pain Helps distinguish chest pain caused by cardiac conditions from other non-cardiac causes

Patients presenting to the emergency department with suspected heart attack symptoms Such as chest pain, shortness of breath, or cold sweating Hospitalized patients diagnosed with myocardial infarction To monitor enzyme peak levels and their return to baseline Patients after cardiac interventional procedures Such as coronary angioplasty or bypass surgery, to detect any new cardiac injury

Severe chest pain or pressure lasting more than a few minutes Pain radiating to the shoulder, arm, back, neck, or jaw Shortness of breath with or without chest pain Nausea, dizziness, or sudden cold sweating

Normal CK-MB level Typically less than 5-7 ng/mL or less than 3-5% of total CK Diagnostic level for myocardial infarction Clinically significant when it exceeds the reference range (usually > 7-10 ng/mL) or when CK-MB constitutes more than 5% of total CK, enhancing its cardiac specificity

CK-MB Heart Enzyme Test | Lahalak Medical Platform

A specialized test measuring cardiac-specific enzymes, assisting in the rapid and accurate diagnosis of heart muscle injury to ensure appropriate medical intervention at the ideal time.

Scientific name: Creatine Kinase MB (CK-MB) Test

A quantitative test that measures the level of the MB isoenzyme of creatine kinase (CK) in blood serum. CK is an enzyme found in muscles and exists in three isoenzyme forms: MM (skeletal muscle), MB (primarily cardiac muscle), and BB (brain). CK-MB is more specific to the heart than total CK, as it constitutes about 15–30% of total CK in cardiac mu...

Creatine Kinase MB (CK-MB) Test - Check Your Heart Muscle Health

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Included Services

Creatine Kinase MB (CK MB)
Consultation for results interpretation with a cardiology specialist or an emergency physician.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Diagnosis of acute myocardial infarction (heart attack) Used especially when detected alongside ECG changes and clinical symptoms and was previously a primary diagnostic marker
Assessment of the extent of myocardial damage Peak elevation generally correlates with the size of the affected area of the heart
Detection of reinfarction In hospitalized patients with prior myocardial infarction where a new rise after normalization may indicate a new event
Differentiation of cardiac versus non-cardiac chest pain Helps distinguish chest pain caused by cardiac conditions from other non-cardiac causes

Recommended groups

Patients presenting to the emergency department with suspected heart attack symptoms Such as chest pain, shortness of breath, or cold sweating
Hospitalized patients diagnosed with myocardial infarction To monitor enzyme peak levels and their return to baseline
Patients after cardiac interventional procedures Such as coronary angioplasty or bypass surgery, to detect any new cardiac injury

Symptoms indicative

Severe chest pain or pressure lasting more than a few minutes
Pain radiating to the shoulder, arm, back, neck, or jaw
Shortness of breath with or without chest pain
Nausea, dizziness, or sudden cold sweating

Frequently Asked Questions (FAQs)

What is the difference between CK-MB and Troponin?
Can CK-MB rise for reasons other than a heart attack? Yes, it can rise in conditions that damage muscles containing CK-MB, such as:
Why is CK-MB still sometimes requested along with Troponin? Cost: may be cheaper in some regions Timing of injury: short half-life helps determine if the injury is very recent (elevated CK-MB but normal Troponin) Assessment of infarct size: by calculating the area under its elevation curve Protocol tradition: some hospitals still include it in their protocol
Why is CK-MB still sometimes requested along with Troponin?
Cost: may be cheaper in some regions
Timing of injury: short half-life helps determine if the injury is very recent (elevated CK-MB but normal Troponin)

Normal Levels

Normal CK-MB level Typically less than 5-7 ng/mL or less than 3-5% of total CK
Diagnostic level for myocardial infarction Clinically significant when it exceeds the reference range (usually > 7-10 ng/mL) or when CK-MB constitutes more than 5% of total CK, enhancing its cardiac specificity

Conditions & Notices

• Fasting is not required; however, the sample is usually taken when symptoms are suspected.
• Serial samples should be taken (for example, at presentation and then after 6–12 hours) to assess the pattern of rise and peak.
• The sample is collected in a serum tube (red or yellow cap).
• The physician should be informed of any recent muscle injury or intense physical exercise, as these may elevate total CK levels and affect the percentage of CK-MB.